Naomi Goldfinger

Rehovot, M, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Mutant p53 reactivation restricts the protumorigenic consequences of wild type p53 loss of heterozygosity in Li-Fraumeni syndrome patient-derived fibroblasts.

Mutant p53 reactivation restricts the protumorigenic consequences of wild type p53 loss of heterozygosity in Li-Fraumeni syndrome patient-derived fibroblasts.

Journal: Cell death and differentiation

Published: August 07, 2023

Egr1 regulates regenerative senescence and cardiac repair.

Egr1 regulates regenerative senescence and cardiac repair.

Journal: Nature cardiovascular research

Published: May 01, 2023

Correction: Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides.

Correction: Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides.

Journal: Oncotarget

Published: June 14, 2019

Retraction: Transactivation of the EGR1 Gene Contributes to Mutant p53 Gain of Function.

Retraction: Transactivation of the EGR1 Gene Contributes to Mutant p53 Gain of Function.

Journal: Cancer research

Published: April 17, 2019

Mutant p53-dependent mitochondrial metabolic alterations in a mesenchymal stem cell-based model of progressive malignancy.

Mutant p53-dependent mitochondrial metabolic alterations in a mesenchymal stem cell-based model of progressive malignancy.

Journal: Cell death and differentiation

Published: June 07, 2018

A Mutant p53-Dependent Embryonic Stem Cell Gene Signature Is Associated with Augmented Tumorigenesis of Stem Cells.

A Mutant p53-Dependent Embryonic Stem Cell Gene Signature Is Associated with Augmented Tumorigenesis of Stem Cells.

Journal: Cancer research

Published: March 16, 2018

Various stress stimuli rewire the profile of liver secretome in a p53-dependent manner.

Various stress stimuli rewire the profile of liver secretome in a p53-dependent manner.

Journal: Cell death & disease

Published: February 04, 2018

Post-translational regulation of p53 function through 20S proteasome-mediated cleavage.

Post-translational regulation of p53 function through 20S proteasome-mediated cleavage.

Journal: Cell death and differentiation

Published: February 26, 2017

Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers.

Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers.

Journal: Oncogene

Published: September 11, 2016

Immune deficiency augments the prevalence of p53 loss of heterozygosity in spontaneous tumors but not bi-directional loss of heterozygosity in bone marrow progenitors.

Immune deficiency augments the prevalence of p53 loss of heterozygosity in spontaneous tumors but not bi-directional loss of heterozygosity in bone marrow progenitors.

Journal: International journal of cancer

Published: August 04, 2016

Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides.

Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides.

Journal: Oncotarget

Published: November 29, 2015

Novel p53 target genes secreted by the liver are involved in non-cell-autonomous regulation.

Novel p53 target genes secreted by the liver are involved in non-cell-autonomous regulation.

Journal: Cell death and differentiation

Published: February 18, 2015

Showing 1-12 of 22

Last Updated: 09/26/2026